Abstract:BACKGROUND:E2F1 is the gatekeeper of the cell cycle controlling an analogous balance between proliferation and cell death. E2F1 expression is elevated in advanced prostate cancer. However, it is still unclear that the roles and mechanisms of E2F1 on prostate cancers.METHODS:Targeted knockdown by interferon RNA was applied on two prostate cancer and Hela cell lines to examine the inverse correlation expression of E2F1 and ICAM-1. ICAM-1 promoter reporter and ChIP assays were used for analysis of the molecular basis of transcriptional regulation of E2F1 on ICAM-1. Co-IP assays were employed for testing the protein interaction between E2F1 and NF-κB. Tumor xenograft mice model with E2F1 and ICAM-1-knockdown prostate cancer cells were used to investigate the effects of E2F1 and ICAM-1 on antitumor immunity.RESULTS:E2F1 knockdown by a specific short hairpin RNA increased gene transcription and protein expression of ICAM-1. By using wild type and a series of mutant ICAM-1 promoter luciferase constructs, the NF-κB binding sites were found to be important for E2F1 regulation of ICAM-1 promoter. Targeted knockdown of E2F1 did not affect expression and phosphorylation of NF-κB and IκBα, but facilitated NF-κB binding to the ICAM-1 promoter, subsequently induced ICAM-1 transcription and production in prostate carcinoma cells. Furthermore, knockdown of E2F1 inhibited tumor growth of prostate cancer in vivo through increasing the susceptibility of tumor cells to ICAM-1-mediated anti-tumor immunity including enhancement of monocyte adhesion, leucocytes infiltration, as well as cytotoxicity against tumor cells.CONCLUSIONS:E2F1 knockdown inhibited prostate tumor growth in vitro and in vivo through sensitizing tumor cells to ICAM-1 mediated anti-immunity by NF-κB modulation, highlighting the potential of E2F1 as a therapeutic target.

Ifn Gamma-Induced Ifit5 Promotes Epithelial-To-Mesenchymal Transition In Prostate Cancer Via Mirna Processing

IFN-r-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via microRNA processing.

IFN-γ Induces Epithelial-to-mesenchymal Transition of Cancer Cells Via an Unique Microrna Processing

Identification of IFN-Induced Transmembrane Protein 1 with Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis.

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

Interferon-induced IFIT5 Promotes Epithelial-to-mesenchymal Transition Leading to Renal Cancer Invasion.

IFN-γ Induces the Upregulation of RFXAP Via Inhibition of Mir-212-3p in Pancreatic Cancer Cells: A Novel Mechanism for IFN-γ Response.

MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1

Interferon-gamma signaling promotes melanoma progression and metastasis

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression

Intratumoral Injection of Interferon Gamma Promotes the Efficacy of Anti-Pd1 Treatment in Colorectal Cancer

IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway

IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling

Interferon- inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3/-catenin pathway in glioma

Interferon‐γ Inducible Protein 30 Promotes the Epithelial–mesenchymal Transition‐like Phenotype and Chemoresistance by Activating EGFR/AKT/GSK3β/β‐catenin Pathway in Glioma

IFITM10 Enhance Tumor Angiogenesis and Promotes Cancer Progression through STAT3 Activation

Expression Profiling Of A Human Cell Line Model Of Prostatic Cancer Reveals A Direct Involvement Of Interferon Signaling In Prostate Tumor Progression

Low-dose IFN-γ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer

MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells

Microrna-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor Tfpi-2

Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer